Showing results (41-50 of 229) with videos related to

Sort By:
Pageof 23
Arthritis Research & Therapy|July 29, 2021
Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory modelsJohn A Reynolds, Jennifer Prattley, Nophar Geifman, et al.
Frontiers in Immunology|May 22, 2023
Automated clustering reveals CD4+ T cell subset imbalances in rheumatoid arthritisBen Mulhearn, Lysette Marshall, Megan Sutcliffe, et al.
Autoimmunity|November 28, 2024
High throughput multiplex immunoassays stratify patients according to symptom burden across the anti-Ro positive systemic autoimmune rheumatic disease spectrumSarah Dyball, Rudresh Shukla, Anastasia-Vasiliki Madenidou, et al.
The Lancet. Rheumatology|January 22, 2024
Early infection risk in patients with systemic lupus erythematosus treated with rituximab or belimumab from the British Isles Lupus Assessment Group Biologics Register (BILAG-BR): a prospective longitudinal studyMia Rodziewicz, Sarah Dyball, Mark Lunt, et al.
Seminars in Arthritis and Rheumatism|January 7, 2024
Predictors and prognostic factors influencing outcomes of anti-CD20 monoclonal antibodies in systemic lupus erythematosus: A systematic review updateMia Rodziewicz, Claudia Mendoza-Pinto, Sarah Dyball, et al.
Lupus Science & Medicine|January 13, 2023
Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trialsIan N Bruce, Ronald F van Vollenhoven, Konstantina Psachoulia, et al.
Annals of the Rheumatic Diseases|April 14, 2019
Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changesMichelle Barraclough, Shane McKie, Ben Parker, et al.
Clinical and Experimental Rheumatology|January 9, 2013
Certolizumab pegol attenuates the pro-inflammatory state in endothelial cells in a manner that is atheroprotectiveSarah K Heathfield, Benjamin Parker, Leo A H Zeef, et al.
Seminars in Arthritis and Rheumatism|March 23, 2017
Can we identify who gets benefit or harm from mycophenolate mofetil in systemic lupus erythematosus? A systematic reviewClaudia Mendoza-Pinto, Carmelo Pirone, Daniëlle A van der Windt, et al.
Oxford Medical Case Reports|June 1, 2023
A successful antenatal outcome in a patient with refractory Takayasu's arteritis treated with tocilizumab throughout pregnancy-a case reportBehram Khan, Trixy David, Jon Sussman, et al.
Pageof 23